---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-031268"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2024-10-15T23:59:59+00:00"
generated_at: "2026-05-30T14:38:25.927639+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NRx Pharma closes $5.435M second tranche of secured notes; cancels third tranche

## Summary
- On Oct 10, 2024, closed second tranche: $5.435M principal amount of Senior Secured Convertible Notes (purchase price ~$5.0M) and warrants for 1,846,128 shares.
- Proceeds to repay existing variable priced convertible notes and for general working capital.
- Conversion price is lower of $1.7664 or 92% of lowest 7-day VWAP prior to conversion date.
- Company and investor mutually agreed not to proceed with the third $5.435M tranche.
- Placement agent EF Hutton receives 7% cash fee and up to $50,000 expense reimbursement.

## SEC filing metadata
- accession: 0001437749-24-031268
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2024-10-15T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000143774924031268/0001437749-24-031268-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000143774924031268/nrxp20241014_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-031268
- JSON: https://secwatch.observer/filing/0001437749-24-031268.json
- Plain text: https://secwatch.observer/filing/0001437749-24-031268.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.